7 min read
Dermatological Research Peptides
Copper peptides and growth factors in collagen synthesis and ECM remodelling research.
The Science of Peptide-Driven Skin Renewal
Skin aging is associated with progressive loss of collagen, elastin, and extracellular matrix (ECM) integrity. Published research indicates collagen production declines approximately 1% per year from age 40, with corresponding changes in tissue structure. Research peptides that modulate ECM biosynthesis — particularly GHK-Cu — are among the most studied compounds in dermatological science.
GHK-Cu: The Copper Peptide
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that declines with age. Research has shown it modulates expression of over 4,000 human genes, with a net effect of restoring gene activity to a more youthful pattern. Key actions include: stimulation of collagen I, III, and V synthesis; increased production of decorin (which regulates collagen fibril assembly); upregulation of VEGF (promoting blood vessel growth to skin); and enhanced activity of metalloproteinases that remodel damaged ECM tissue.
BPC-157 in Dermatological Research
While BPC-157 is primarily studied in gut and tendon tissue research, its observed angiogenic properties — the promotion of new blood vessel formation — have made it a subject of dermatological research in animal models. Animal studies have documented effects on wound closure timing, scar formation, and tissue remodelling in rodent skin models. Its interaction with the nitric oxide pathway is a proposed mechanism observed in preclinical research.
Blended Research Approaches
Some researchers investigate multi-peptide approaches. The combination of BPC-157 (tissue repair), TB-500 (cell migration and angiogenesis), and GHK-Cu (collagen synthesis and ECM remodelling) represents a multi-pathway approach to skin regeneration research. Each compound targets a different mechanism, and their combined use is a growing area of interest in the regenerative medicine literature.
Practical Research Considerations
GHK-Cu is typically available in 50–200mg lyophilised form for research use. It is also found in topical cosmetic formulations, though the research-grade form has distinct properties from cosmetic creams. Storage at -20°C preserves potency for 12–24 months. Once reconstituted, refrigerate and use within 28 days.
Research Disclaimer: All content on this page is provided for educational and informational purposes only and relates strictly to published preclinical research. Silver Peptide products are supplied for in vitro laboratory research use only. They are not approved by the MHRA, FDA, or any regulatory body for human consumption, injection, or veterinary use. They are not medicines and must not be used as such. Nothing on this page constitutes medical advice.